GST Department conducts search at Mankind Pharma's subsidiary BSV

Enforcement RaidRegulatory & Legal View source PDF Explain this filing

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.2%Reaction day

₹2060.00

prior close

₹2083.40

announcement price

In-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+1.6%-0.4% vs market

Pharmaceuticals peers, median of 159sector+1.8%-0.7% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Midcap 150 and 0.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.2

15m

+0.0

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.2+1.6-0.4+1.8-0.7

Next day

+0.6+2.0-1.4+2.4-1.8

+1.3+2.0-0.7+2.0-0.7

+1.0+1.5-0.5+1.3-0.3

+0.0-0.2+0.2+0.7-0.7

+1.0+0.2+0.7+0.0+1.0

+0.7+1.1-0.4+0.8-0.1

15d

+9.2-2.1+11.3-4.4+13.6

+5.0-5.4+10.4-5.3+10.2

-0.3-4.4+4.0-3.0+2.6

+19.3+2.7+16.6+4.6+14.7

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mankind Pharma's wholly owned subsidiary Bharat Serums and Vaccines (BSV) underwent a search and inspection by the GST Department, Mumbai, from Feb 3 to Feb 8, 2026. The inquiry covered tax payments, input tax credit claims, reconciliation and refunds. BSV fully cooperated with officials and the company says there is no material impact on financials or operations, with business running as usual during the inspection.

Likely market impact

Short-term negative sentiment possible, but management says no material impact on operations or financials of subsidiary BSV.